PDCD1 and infantile convulsions and choreoathetosis: In conclusion, this retrospective study provided preliminary evidence that FOLFOX-HAIC in combination with lenvatinib and PD-1 inhibitor showed a promising antitumor activity with manageable safety profiles in advanced iCCA.